362 related articles for article (PubMed ID: 17399839)
1. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
2. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
3. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
4. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
6. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
7. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?
Ankola DD; Viswanad B; Bhardwaj V; Ramarao P; Kumar MN
Eur J Pharm Biopharm; 2007 Sep; 67(2):361-9. PubMed ID: 17452099
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticulate delivery can improve peroral bioavailability of cyclosporine and match Neoral Cmax sparing the kidney from damage.
Ankola DD; Wadsworth RM; Ravi Kumar MN
J Biomed Nanotechnol; 2011 Apr; 7(2):300-7. PubMed ID: 21702368
[TBL] [Abstract][Full Text] [Related]
10. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
Mainardes RM; Evangelista RC
Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139
[TBL] [Abstract][Full Text] [Related]
13. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
15. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of spray dried PLGA/amifostine nanoparticles.
Pamujula S; Graves RA; Freeman T; Srinivasan V; Bostanian LA; Kishore V; Mandal TK
J Pharm Pharmacol; 2004 Sep; 56(9):1119-25. PubMed ID: 15324480
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and epsilon-caprolactone: comparison with conventional PLGA microspheres.
Li Y; Zhu KJ; Zhang JX; Jiang HL; Liu JH; Hao YL; Yasuda H; Ichimaru A; Yamamoto K
Int J Pharm; 2005 May; 295(1-2):67-76. PubMed ID: 15847992
[TBL] [Abstract][Full Text] [Related]
18. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
20. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
Sahana DK; Mittal G; Bhardwaj V; Kumar MN
J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
